These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 26707870

  • 1. Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
    Messai Y, Gad S, Noman MZ, Le Teuff G, Couve S, Janji B, Kammerer SF, Rioux-Leclerc N, Hasmim M, Ferlicot S, Baud V, Mejean A, Mole DR, Richard S, Eggermont AM, Albiges L, Mami-Chouaib F, Escudier B, Chouaib S.
    Eur Urol; 2016 Oct; 70(4):623-632. PubMed ID: 26707870
    [Abstract] [Full Text] [Related]

  • 2. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K, Zhang N, Na X, Wu G, Yang XY, Xin DQ, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2005 Mar 15; 43(6):390-3. PubMed ID: 15854350
    [Abstract] [Full Text] [Related]

  • 3. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.
    Greene CJ, Sharma NJ, Fiorica PN, Forrester E, Smith GJ, Gross KW, Kauffman EC.
    Free Radic Biol Med; 2019 Mar 15; 133():295-309. PubMed ID: 30553971
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 5. Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features.
    Hong B, Cai L, Wang J, Liu S, Zhou J, Ma K, Zhang J, Zhou B, Peng X, Zhang N, Gong K.
    Clin Genitourin Cancer; 2019 Apr 16; 17(2):97-104.e1. PubMed ID: 30522901
    [Abstract] [Full Text] [Related]

  • 6. Dissection of PD-L1 promoter reveals differential transcriptional regulation of PD-L1 in VHL mutant clear cell renal cell carcinoma.
    Kong SK, Kim BS, Lim H, Kim HJ, Kim YS.
    Lab Invest; 2022 Apr 16; 102(4):352-362. PubMed ID: 34789838
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.
    Schödel J, Grampp S, Maher ER, Moch H, Ratcliffe PJ, Russo P, Mole DR.
    Eur Urol; 2016 Apr 16; 69(4):646-657. PubMed ID: 26298207
    [Abstract] [Full Text] [Related]

  • 8. [Activation of HIF-1α/ACLY signaling axis promotes progression of clear cell renal cell carcinoma with VHL inactivation mutation].
    Ma Y, Wang YH, Huang S, Zou ZG, Hu L, Guo LC.
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec 08; 52(12):1230-1236. PubMed ID: 38058039
    [Abstract] [Full Text] [Related]

  • 9. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
    Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H.
    Oncogene; 2012 Feb 09; 31(6):776-86. PubMed ID: 21725364
    [Abstract] [Full Text] [Related]

  • 10. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K, Zhang N, Zhang K, Na Y.
    Int J Mol Med; 2010 Dec 09; 26(6):907-12. PubMed ID: 21042786
    [Abstract] [Full Text] [Related]

  • 11. Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.
    Damjanovic SS, Ilic BB, Beleslin Cokic BB, Antic JA, Bankovic JZ, Milicevic IT, Rodic GS, Ilic DS, Todorovic VN, Puskas N, Tulic CD.
    Exp Mol Pathol; 2016 Dec 09; 101(3):323-331. PubMed ID: 27845047
    [Abstract] [Full Text] [Related]

  • 12. Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation.
    Chan KH, Li N, Lador R, Amsbaugh M, Gonzalez A, Cen P.
    J Investig Med High Impact Case Rep; 2024 Dec 09; 12():23247096241231641. PubMed ID: 38344974
    [Abstract] [Full Text] [Related]

  • 13. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
    Petrella BL, Brinckerhoff CE.
    Cancer Biol Ther; 2009 Jul 09; 8(14):1389-401. PubMed ID: 19483472
    [Abstract] [Full Text] [Related]

  • 14. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
    Chintala S, Najrana T, Toth K, Cao S, Durrani FA, Pili R, Rustum YM.
    BMC Cancer; 2012 Jul 17; 12():293. PubMed ID: 22804960
    [Abstract] [Full Text] [Related]

  • 15. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, Katsuyama Y, Melillo G, Konishi I.
    Hum Pathol; 2007 Sep 17; 38(9):1310-20. PubMed ID: 17555795
    [Abstract] [Full Text] [Related]

  • 16. Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma.
    Kong HS, Lee S, Beebe K, Scroggins B, Gupta G, Lee MJ, Jung YJ, Trepel J, Neckers L.
    Mol Pharmacol; 2010 Dec 17; 78(6):1072-8. PubMed ID: 20813864
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element.
    Xu J, Wang B, Xu Y, Sun L, Tian W, Shukla D, Barod R, Grillari J, Grillari-Voglauer R, Maxwell PH, Esteban MA.
    Oncogene; 2012 Feb 23; 31(8):1065-72. PubMed ID: 21841824
    [Abstract] [Full Text] [Related]

  • 18. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
    Fan Y, Li H, Ma X, Gao Y, Bao X, Du Q, Ma M, Liu K, Yao Y, Huang Q, Zhang Y, Zhang X.
    Oncotarget; 2016 Apr 05; 7(14):18280-94. PubMed ID: 26943772
    [Abstract] [Full Text] [Related]

  • 19. Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells.
    Wolf C, Smith S, van Wijk SJL.
    Int J Mol Sci; 2022 Mar 25; 23(7):. PubMed ID: 35408930
    [Abstract] [Full Text] [Related]

  • 20. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X, Wu G, Ryan CK, Schoen SR, di'Santagnese PA, Messing EM.
    J Urol; 2003 Aug 25; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.